Table 2 Main clinicopathological and vasculogenic mimicry characteristics of all relevant studies
First author (Ref.) | VM state n (%) | Methods of VM assay | Clark levela | Location | |||||
|---|---|---|---|---|---|---|---|---|---|
VM+ | VM- | ІІІ | ІV | V | Head and neck | Trunk | Extremities | ||
Maniotis AJ, [34] | 106 (45) | 128 (55) | PAS | – | 234 | – | 234 | – | – |
Massi D, [35] | 15 (30) | 30 (70) | CD31/PAS | – | 45 | – | 6 | 21 | 18 |
Hillen F, [37] | 22 (38) | 36 (78) | PAS | 12 | 22 | 24 | 6 | 17 | 22 |
Zhang SH, [38] | 54 (43) | 70 (57) | PAS | – | 65 | 59 | 16 | 46 | 62 |
Shi L, [39] | 11 (27) | 34 (73) | CD31/PAS | 33 | 12 | – | 32 | 13 | – |
Beurden BV, [40] | 42 (34) | 81 (66) | PAS | 23 | 51 | 49 | – | 112 | 11 |
Itzhaki O, [41] | 14 (93) | 1 (7) | CD31/PAS | 2 | 8 | 5 | 2 | 10 | 3 |
Song H, [42] | 25 (41) | 37 (59) | CD31/PAS | 14 | 45 | 3 | 62 | – | – |
Baocun S, [43] | 10 (5) | 50 (95) | CD31/PAS | – | 38 | 22 | NA | NA | NA |
Zhao X, [44] | 36 (45) | 43 (55) | CD34/PAS | 46 | 33 | – | 21 | 43 | 15 |
Liang X, [45] | 35 (43) | 46 (57) | CD34/PAS | – | 41 | 40 | 34 | 28 | 19 |
Zhang W, [46] | 106 (45) | 128 (55) | CD34/PAS | – | 22 | 30 | 22 | 16 | 14 |